deltatrials
Recruiting PHASE1/PHASE2 INTERVENTIONAL 6-arm NCT02584244

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

Sponsor: Lumicell, Inc.

Conditions Colorectal Cancer Esophageal Cancer Gastric Cancer Pancreatic Cancer
Interventions LUM 2.6 Imaging Device LUM015
Updated 16 times since 2017 Last updated: Jan 15, 2026 Started: Aug 4, 2016 Primary completion: Dec 31, 2026 Completion: Apr 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02584244, this PHASE1/PHASE2 trial focuses on Colorectal Cancer and Esophageal Cancer and remains actively recruiting participants. Sponsored by Lumicell, Inc., it has been updated 16 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Dec 2017 · 10 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jan 2020 · 19 months · monthly snapshot~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Mar 2022 · 12 months · monthly snapshot~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshot~Sep 2022 – ~Jun 2023 · 9 months · monthly snapshot~Jun 2023 – ~Apr 2024 · 10 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Feb 2026 · 12 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

16 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting PHASE1/PHASE2

  2. Feb 2025 — Feb 2026 [monthly]

    Recruiting PHASE1/PHASE2

  3. Sep 2024 — Feb 2025 [monthly]

    Recruiting PHASE1/PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  5. Apr 2024 — Jul 2024 [monthly]

    Recruiting PHASE1_PHASE2

▶ Show 11 earlier versions

  1. Jun 2023 — Apr 2024 [monthly]

    Recruiting PHASE1_PHASE2

  2. Sep 2022 — Jun 2023 [monthly]

    Recruiting PHASE1_PHASE2

  3. Mar 2022 — Sep 2022 [monthly]

    Recruiting PHASE1_PHASE2

  4. Mar 2021 — Mar 2022 [monthly]

    Recruiting PHASE1_PHASE2

  5. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE1_PHASE2

  6. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Unknown Status → Recruiting

  7. Jan 2020 — Mar 2020 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Recruiting → Unknown Status

  8. Jun 2018 — Jan 2020 [monthly]

    Recruiting PHASE1_PHASE2

  9. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

    Phase: NA → PHASE1_PHASE2

  10. Feb 2017 — Dec 2017 [monthly]

    Recruiting NA

  11. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Lumicell, Inc.
  • National Cancer Institute (NCI)
Data source: Lumicell, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations